Exhibit A to Deposit AgreementAmerican Depositary Receipt • January 27th, 2017 • Minebea Mitsumi Inc./Adr
Contract Type FiledJanuary 27th, 2017 CompanyThe Bank of New York as depositary (hereinafter called (the "Depositary"), hereby certifies that _________________________ _________________________________________________, or registered assigns IS THE OWNER OF
Exhibit A to Deposit Agreement THE RIGHT, IF ANY, OF THE OWNER OF THE AMERICAN DEPOSITARY SHARES EVIDENCED BY THIS RECEIPT TO VOTE THE DEPOSITED SECURITIES REPRESENTED BY SUCH AMERICAN DEPOSITARY SHARES MAY BE SUSPENDED OR REVOKED PURSUANT TO THE...American Depositary Receipt • December 23rd, 2015 • Lonmin PLC /ADR • American depositary receipts
Contract Type FiledDecember 23rd, 2015 Company IndustryThe Bank of New York as depositary (hereinafter called the “Depositary”), hereby certifies that ____________________________________________________________, or registered assigns IS THE OWNER OF ____________________________
Exhibit A to Deposit AgreementAmerican Depositary Receipt • January 20th, 2015 • Genetic Technologies LTD • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 20th, 2015 Company IndustryThe Bank of New York as depositary (hereinafter called the "Depositary"), hereby certifies that , or registered assigns IS THE OWNER OF ______________________
Exhibit A to Deposit AgreementAmerican Depositary Receipt • April 26th, 2004 • Anglogold LTD • Gold and silver ores
Contract Type FiledApril 26th, 2004 Company IndustryThe Bank of New York as depositary (hereinafter called the "Depositary"), hereby certifies that _____________________________________________________________ ____________________________________________________________, or registered assigns IS THE OWNER OF _________________________________
Exhibit A to Deposit AgreementAmerican Depositary Receipt • January 6th, 2004 • Xenova Group PLC • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 6th, 2004 Company IndustryCERTAIN RIGHTS OF THE OWNER OF THE AMERICAN DEPOSITARY SHARES EVIDENCED BY THIS RECEIPT UNDER ARTICLES 3, 12 AND 16 OF THIS RECEIPT MAY BE SUSPENDED OR REVOKED PURSUANT TO THE PROVISIONS OF ARTICLE 22 OF THIS RECEIPT
Exhibit A to Deposit AgreementAmerican Depositary Receipt • October 21st, 2003 • Braskem Sa • Industrial organic chemicals
Contract Type FiledOctober 21st, 2003 Company IndustryThe Bank of New York as depositary (hereinafter called the "Depositary"), hereby certifies that , or registered assigns IS THE OWNER OF
EXHIBIT A TO DEPOSIT AGREEMENTAmerican Depositary Receipt • May 1st, 2003 • Veolia Environnement • Refuse systems
Contract Type FiledMay 1st, 2003 Company IndustryThe Bank of New York, as depositary (hereinafter called the "Depositary"), hereby certifies that___________________________________________ __________________________________, or registered assigns IS THE OWNER OF __________________________________________________________.
THE RIGHTS OF OWNERS OF RECEIPTS TO DIRECT THE VOTING OF SHARES MAY BE RESTRICTED AS DESCRIBED IN ARTICLES 16 AND 23 BELOW Exhibit A to Deposit AgreementAmerican Depositary Receipt • April 23rd, 2003 • British Biotech PLC • Pharmaceutical preparations
Contract Type FiledApril 23rd, 2003 Company IndustryThe Bank of New York as depositary (hereinafter called the "Depositary"), hereby certifies that ____________________________________________________ _____________________________________, or registered assigns IS THE OWNER OF ____________________________________ AMERICAN DEPOSITARY SHARES representing deposited Ordinary Shares of 5p nominal value per share (herein called "Shares") of British Biotech plc, an English public limited company (herein called the "Company"). At the date hereof, each American Depositary Share represents forty Shares deposited or subject to deposit under the deposit agreement at the London office of The Bank of New York, as custodian (herein called the "Custodian"). The Depositary's Corporate Trust Office is located at a different address than its principal executive office. Its Corporate Trust Office is located at 101 Barclay Street, New York, N.Y. 10286, and its principal executive office is located at One Wall Street, New York, N.Y. 10286.